Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma

Overview of attention for article published in International Journal of Hematology, March 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 16,468 followers.

Monosomy 13 in metaphase chromosomes associated with inferior outcome to Velcade/Decadron in relapsed #myeloma (http://t.co/rt8oDmF3).

[Springer전자책] Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexame... http://t.co/BNBRtgAs